Seeking Alpha

JNJ's Janssen Biotech unit requests FDA approval of Simponi, its investigational intravenous...

JNJ's Janssen Biotech unit requests FDA approval of Simponi, its investigational intravenous formulation for the treatment of adults with moderately to severely active rheumatoid arthritis.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)